First nasal spray for treating adult COVID-19 patients launched in India \
3 min read
\
\

First nasal spray for treating adult COVID-19 patients launched in India

09-Feb-2022
New Delhi [India], February 9 (ANI): Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
09-Feb-2022 National
\